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Available online 14 January 2016Skin ﬁbroblastswere obtained from a 46-year-old symptomaticman carrying aM146Imutation in the presenilin
1 gene (PSEN1), responsible for causing Alzheimer's disease (AD). Induced pluripotent stem cells (iPSCs) were
derived via transfection with episomal vectors carrying hOCT4, hSOX2, hKLF2, hL-MYC, hLIN28 and shTP53
genes. M146I-iPSCs were free of genomically integrated reprogramming genes, had the speciﬁc mutation but
no additional genomic aberrancies, expressed the expected pluripotencymarkers and displayed in vitro differen-
tiation potential to the three germ layers. The reported M146I-iPSCs line may be a useful resource for in vitro
modeling of familial AD.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Resource Tableame of stem cell construct M146I-hiPSC
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ate archived/stock date September 2015
rigin Human skin ﬁbroblasts
ype of resource Biological reagent: induced pluripotent stem
cells (iPSCs); derived from PSEN1M146I
heterozygous mutation patientub-type Induced pluripotent stem cells (iPSCs)
ey transcription factors hOCT4, hSOX2, hKLF4, hL-MYC, hLIN28, and
shRNA against TP53
(Addgene plasmids 27,077, 27,078 and 27,080;
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(Fig. 1)nk to related literature (direct
URL links and full references)N/Aformation in public databases N/AIn. This is an open access article underResource Details
The study was approved by the “De Videnskabsetiske Komiteer for
Region Hovedstaden” (protocol number H-4-2011-157), Copenhagen,
Denmark and written informed consent was obtained in all cases. To
protect patient family privacy, no personal patient information is pre-
sented here. A skin biopsy was obtained from a 46-year-old man carry-
ing a heterozygous mutation in exon 5 of presenilin 1 (PSEN1) gene
causing a change in amino acid M146I. Mutations in PSEN1 are the
most common cause of inherited Alzheimer's disease (AD). The mother
of the patient died of AD at the age of 42, and DNA formolecular genetic
testing from her was not available. He had had cognitive symptoms
since the age of 41, blurred by affective symptoms. He was diagnosed
with AD at the age of 43. Episomal plasmids carrying gene sequences
for hOCT4, hSOX2, hKLF4, hL-MYC, hLIN28 and a short hairpin against
TP53 (Okita et al., 2011) were used to reprogram the ﬁbroblasts into
iPSCs. This technique was previously successfully established for gener-
ation of integration and feeder-free iPSCs (Rasmussen et al., 2014).
24 days after reprogramming, several iPSC colonies were picked for fur-
ther selection and expansion as single cells. Episomal plasmid integra-
tion was analyzed by qPCR with DNA from iPSCs at passage 10 with
plasmid-speciﬁc primers, using DNA from human ﬁbroblasts as control.
The analysis conﬁrmed that the reprogramming genes hOCT4, hSOX2
and hLIN28 were absent and had, consequently, not integrated into
the genome (Fig. 1A). The clones were karyotypically normal (Fig. 1E)
and the mutation was sequenced and conﬁrmed by the presence of a
c.438 G N C change in exon 5 of the PSEN1 gene corresponding to athe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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to analyze the pluripotency marker expression at the mRNA level,
which showed that the endogenous pluripotency genes OCT4,
DMNT3B, GABRG3, NANOG, TDGF1, GDF3, SOX2 and ZFP42 were
slightly upregulated compared to human embryonic stem cells
(hESCs) (Fig. 1C). At the protein level, immunocytochemical (ICC)
analysis conﬁrmed the expression of the pluripotency markers
OCT4, NANOG, SSEA3, SSEA4, TRA-1-60 and TRA-1-81 (Fig. 1D). Fur-
thermore, in vitro differentiation followed by ICC analysis of the endo-
dermal marker α-feto protein (AFP), the mesodermal marker smooth
muscle actin (SMA) and the ectodermalmarker β-III tubulin (TUJI) con-
ﬁrmed the ability of the iPSCs to differentiate into all three germ layers
(Fig. 1F).
Materials and methods
Reprogramming of ﬁbroblasts and establishment of iPSC lines
A skin biopsy was obtained from a 46-year-old man carrying a
M146I mutation in exon 5 of presenilin 1 (PSEN1) gene. The biopsies
were cut into small pieces and left undisturbed in Dulbecco's ModiﬁedFig. 1. A. Quantitative PCR (qPCR)with DNA from ﬁbroblasts andM146I-iPSCs with plasmid-spe
with GAPDH as reference, ﬁbroblasts as negative control and a ﬁbroblast linewith all factors gen
showing a heterozygous c.438 G N C substitution. C. Quantitative reverse-transcriptase PCR (qR
OCT4, DMNT3B, GABRG3, NANOG, TDGF1, GDF3, SOX2 and ZFP42 normalized to GAPDH and hE
hESCs (hESCs = 1). D. Immunocytochemical detection in iPSCS of the pluripotency markers, NEagle Medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), 2 mM L-glutamine and 1% of penicillin and streptomycin
(Pen/Strep) for 10 days to allow ﬁbroblasts to grow out from the biopsy.
After 10 days, media was changed every 2–3 days to expand culture be-
fore ﬁbroblasts were frozen for storage. 1 × 105 ﬁbroblasts were
electroporated with a total of 1 μg carrying the sequences for hOCT4,
hSOX2, hKLF4, hL-MYC and hLIN28 with or without a short hairpin
against TP53 (shp53) (Addgene, Ca, USA plasmids 27,076, 27,077,
27,078 and 27,080; Okita et al., 2011) and cultured in ﬁbroblast medi-
um. Electroporationwas performedwith Neon™ electroporation device
with two pulses at 1200 V for 20 ms (Life Technologies, Carlsbad, CA,
USA). 7 days after electroporation, the ﬁbroblasts were trypsinized
and split 1:2 onto hESC-qualiﬁed Matrigel-coated dishes (BD Biosci-
ences, NJ, USA) and cultured in E8 medium (Life Technologies) in 5%
O2, 5% CO2 in N2 with the medium replenished every other day. After
24 days, primary iPSC colonies were dissected out manually and trans-
ferred to new Matrigel-coated 6-well dishes and cultured in E8.
The iPSC lines were split 1:6 every 5–6 days with dispase (Stem Cell
Technologies). At passage 10, the iPSC lines were harvested for subse-
quent analyses or frozen in E8mediumwith 10% DMSO (Sigma-Aldrich,
MO, USA) in liquid nitrogen.ciﬁc primers for hOCT4, hSOX2 and hLIN28. Relative expression is shown as the fold change
omically integrated as positive control. B. Sequencing of exon 5 of the PSEN1 gene in iPSCs
T-PCR) with cDNA from M146I-iPSCs vs. hESCs with the endogenous pluripotency genes
SCs. Expression levels of pluripotency markers are comparable to the gene expression in
ANOG, SSEA3, SSEA4, TRA1-60 and TRA1-81. Scale bars correspond to 100 μm.
Fig. 1 (continued).
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DNA and total RNA was puriﬁed from ﬁbroblasts, hESCs and M146I-
iPSCs using DNeasy Blood and Tissue kit and RNeasy mini kit, respec-
tively (Qiagen, Hilden, Germany). Conversion to cDNA was performed
with RevertAid First Strand cDNA synthesis kit (Thermo Scientiﬁc,Wal-
tham, MA, USA). Primers for integration qPCRwere all from Okita et al.,
2011 (Table 2). For plasmid integration analysis, relative quantiﬁcation
was calculated using 2-ΔΔCt normalized to GAPDH as reference gene. As
controls, ﬁbroblasts were used with and without integration. Several
primers were designed for pluripotency markers expression (Table 3)
and relative quantiﬁcation was calculated using 2-ΔΔCt with hESCs as
reference and GAPDH as reference gene.Table 1
Primary antibodies used for immunocytochemistry.
Antibody and host species Dilution Company and
catalog number
Pluripotency rabbit anti-NANOG 1:500 Peprotech, 500-P236
goat anti-OCT4 1:500 Santa Cruz, sc-8628
rat anti-SSEA3 1:100 Biolegend, 330,302
mouse anti-SSEA4 1:100 Biolegend, 330,402
mouse anti-Tra-1-60 1:200 Biolegend, 330,602
mouse anti-Tra-1-81 1:200 Biolegend, 330,702
In vitro
differentiation
rabbit anti-α-1-fetoprotein (AFP)
mouse anti-smooth muscle actin
(SMA)
1:500
1:500
DAKO, A0008
DAKO, M0851
mouse anti-β-III tubulin (TUJI) 1:4000 Sigma-Aldrich,
T8660Sequencing
Sanger sequencing of exon 5 of PSEN1 genewas carried out on anABI
PRISM 310 Genetic Analyzer using a designed set of primers that ﬂank
the mutation site according to standard procedures.
Immunoﬂuorescence staining
iPSCs were ﬁxed with 4% paraformaldehyde (PFA) in PBS for 15min
and stained by standard immunoﬂuorescence staining procedures.
The primary antibodies (Table 1) were visualized with the secondary
antibodies Alexa488 or Alexa594 diluted 1:400 (Life technologies)
and counterstained with Hoechst bisbenzimide 33,258. Images
were acquired with a Leica DMRB-ﬂuorescence microscope (Leica
Microsystems, Wetzlar, Germany).
In vitro differentiation
Embryoid body (EB) formation was performed by transferring
EDTA-treated iPSCs to low attachment plates (Corning, NY, USA) in E8.Table 2
Primers (Okita et al., 2011) used for integration analysis by qPCR.
Forward sequence Reverse sequence
OCT4 5′-CATTCAAACTGAGGTAAGGG-3′ 5′-TAGCGTAAAAGGAGCAACATAG-3′
SOX2 5′-TTCACATGTCCCAGCACTACCA
GA-3′
5′-TTTGTTTGACAGGAGCGACAAT-3′
L-MYC 5′-GGCTGAGAAGAGGATGGC
TAC-3′
5′-CAGGGGGTCTGCTCGCACCGTG
ATG-3′
Table 3
Primers used for pluripotency analysis by qPCR.
Forward sequence Reverse sequence
OCT4 5′-CCCCAGGGCCCCATTTTGGT
ACC-3′
5′-ACCTCAGTTTGAATGCATGGGAGA
GC-3′
NANOG 5′-AAAGAATCTTCACCTATG
CC-3′
5′-GAAGGAAGAGGAGAGACAGT-3′
SOX2 5′-TTCACATGTCCAGCACTACC
AGA-3′
5′-TCACATGTGTGAGAGGGGCAGTGT
GC-3′
DMNT3B 5′-GTGAAGGGGAGGATGGAG
AT-3′
5′-TCTGTGAGGTCGATGGTGAG-3′
GABRG3 5′-ACAGCATTGGTCCTGTGT
CA-3′
5′-GTGAGCCTCTGCGGTTTTAG-3′
TDGF1 5′-ACAGAACCTGCTGCCTGA
AT-3′
5′-ATCACAGCCGGGTAGAAATG-3′
GDF3 5′-TGACCATCTCCCTCAACA
GC-3′
5′-TACCCACACCCACACTCATC-3′
ZFP42 5′-CACTGTGCTGCCTCCAAG-3′ 5′-GCCTATGACTCACTTCCA-3′
5′-ACAGCATTGGTCCTGTGTCA-3′.
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ing 20% knockout serum replacement (Life Technologies), 1× non-
essential amino acids, 2 mM L-glutamine, 0.1 mM 2-mercaptoethanol
and 1% PenStrep. After 7 days, the EBs were plated on 0.5 μg/cm2
vitronectin (Life Technologies) coated dishes and cultured in DMEM
supplemented with 10% FBS, 2 mM L-glutamine and 1% Pen/Strep for
up to three weeks. EBs were ﬁxed for 15 min in 4% PFA for ICC analyses
with the antibodies AFP, SMA and TUJI (Table 1).
Karyotyping
Fibroblasts and M146I-hiPSCs were treated for 45 min with
KaryoMAX colcemid (Life Technologies), harvested in fresh ﬁxative
consisting of 25% acetic acid and 75% methanol and sent for G-band
karyotyping (Cell Guidance Systems, UK).Veriﬁcation and Authentication
Karyotyping was performed by Cell Guidance Systems (UK) and a
minimum of 20 metaphases were analyzed. The results showed a nor-
mal 46, XY karyotype, without any detectable abnormalities (Fig. 1E).
M146I-iPSC line identity and purity was conﬁrmed by sequencing of
PSEN1 (Fig. 1B) and ICC for pluripotency genes expression (Fig. 1D).
E. Representative karyotype of M146I-iPSCs.
F. Immunocytochemical staining of plated embryoid bodies (EBs) on
day 28 with α-fetoprotein (AFP), smooth muscle actin (SMA) and β-III
tubulin (TUJI). Scale bars correspond to 50 μm in AFP and SMA and to
100 μm in TUJI.
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